Abstract: Objective To discuss the application value of early therapy with atorvastatin for stabilize mottle, anti-inflammatory and anti-myocardial ischemia in unstable angina(UA) patients on the basis of routine treatment. Methods Totally 116 cases of unstable angina patients were randomly divided into two groups. Group A (63 cases) were administered atorvastatin 40 mg/d; Group B(53 cases) were administered atorvastatin 10 mg/d.The clinical effect, the electrocardiogram, hs-CRP and lipid conditions before and after the treatment were observed.Results The level of hs-CRP in group A with atorvastatin 40 mg/d declined from (8.97 ± 3.72) to (4.26 ±1.08 ) mg/L, and the level in group B with atorvastatin 10 mg/d declined from (9. 13 ± 3.58) to (6. 10 ± 1. 67) mg/L.The level of hs-CRP declined in both groups( P < 0.05 ). For clinical effect, there were 28 conspicuous effective cases(44.4% ), 30 effective cases(47.6% ), 3 invalid cases(4.8% ) and 2 aggravation cases(3.2% ) in group A;7 conspicuous effective cases( 13.2% ), 8 effective cases( 15.1% ), 28 invalid cases (52.8%) and 10 aggravation cases( 18.9% ) in group B. The total effective rate between the two groups were statistically significant( P < 0. 05 ).For ECG effect, there were 26 conspicuous effective cases(41.3% ), 32 effective cases(50.8% ), 4 invalid cases (6.3%), and 1 aggravation case( 1.6% ) in group A; 6 conspicuous effective cases( 11.3% ), 10 effective cases ( 18.9% ), 26 invalid cases(49.1% ) and 11 aggravation cases ( 20.8% ) in group B. The total effective rate between the two groups were statistically significance( P <0.05 ). In group A, 2 cardiac incidents happened (3.2%)with acute myocardial infarction. 11 cases (20.7%) had the cardiac incidents in group B, including acute myocardial infarction in 10 cases and sudden cardiac death in I case. Total ischemic events rate in group A was lower than that in group B. Conclusion Early intensive therapy with atorvastatin will intervene inflammation, reduce the cardiovascular events and improve the prognosis of UA patients.